Eurobio Scientific: communiqué relatif au dépôt de la note en réponse

Summary by 6ix AI

Eurobio Scientific has filed a response note regarding a public withdrawal offer initiated by EB Development, which is currently under review by the Autorité des marchés financiers. The offer aims to acquire all outstanding shares of Eurobio Scientific not held by the initiator, with a modified offer price announced recently. The board of directors has provided a motivated opinion on the offer's implications for the company and its shareholders, which is included in the response note. The offer will last for a specified period, and any shares not tendered will be subject to a mandatory withdrawal process.

Written in English by 6ix AI from the company’s French-language filing. How 6ix writes summaries